Featured news in The Life Sciences Report
|
|
|
|
Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX) Mesoblast Director Philip R. Krause, M.D., Appointed to Strategic Advisory Role (6/4/2023) |
|
view 
|
|
